Schedule 13G ownership disclosure
Aardvark Therapeutics Inc
Common Stock · CUSIP: 002942100
Event date: 2025-02-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Dr. Finian Tan
Shares: 1,828,258.00 · Class: 8.69%
- Christopher Michael Ho
Shares: 1,694,894.00 · Class: 7.92%
- Vickers Venture Fund VI Pte. Ltd.
Shares: 2,050,902.00 · Class: 9.58%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-016266
- Form type
- SCHEDULE 13G
- Filer
- Aardvark Therapeutics, Inc.
- CIK
- CIK 1774857
- Filed
- Feb 24, 2025
- Reporting period
- Feb 12, 2025
- Description
- Schedule 13G beneficial ownership